# ENABLEX
> **NDA021513** · New Drug Application · Sponsor: ABBVIE · Approved 2004-12-22
## Drug
- **FDA Application Number:** NDA021513
- **Application type:** New Drug Application
- **Brand name:** ENABLEX
- **Generic name:** Darifenacin Hydrobromide
- **Active ingredients:** DARIFENACIN HYDROBROMIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ABBVIE
- **First approval:** 2004-12-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021513)
---
*AI Analytics · CC0 1.0*